Search for a report

GLOBAL DRY EYE DISEASE MARKET FORECAST 2021-2028

  • You are here:
  • Home
  • Downloads
  • GLOBAL DRY EYE DISEASE MARKET FORECAST 2021-2028

GLOBAL DRY EYE DISEASE MARKET FORECAST 2021-2028

The global dry eye disease market is anticipated to register a 5.76% CAGR, generating a revenue of $ 5941.4 million by 2028. The base year considered for the market study is 2020 and the forecasting years are from 2021 to 2028.

Dry eye is a chronic condition that progresses depending upon the severity and cause. Patients diagnosed with dry eye disease do not have sufficient tears to lubricate their eyes.

GLOBAL DRY EYE DISEASE MARKET FORECAST 2021-2028

Global Dry Eye Disease Market by Type (Otc, Prescription) Market by Product (Anti-inflammatory Drugs, Artificial Tears, Punctal Plugs, Secretagogues, Other Products) Market by Distribution Channel (Hospital Pharmacies, Independent Pharmacies and Drug Stores, Online Pharmacies) by Geography

Request free sample

The global dry eye disease market is anticipated to register a 5.76% CAGR, generating a revenue of $ 5941.4 million by 2028. The base year considered for the market study is 2020 and the forecasting years are from 2021 to 2028.

Dry eye is a chronic condition that progresses depending upon the severity and cause. Patients diagnosed with dry eye disease do not have sufficient tears to lubricate their eyes.dry-eye-disease-market

To learn more about this report, request a free sample copy

Key factors propelling the global dry eye disease market growth:

  • Introduction of novel diagnostic techniques for dry eye disease (DED)
    • Technological advancements are being made in the field of ophthalmology.
    • Major companies functioning in the market continuously focus on developing novel therapeutics and diagnostics for dry eye disease.
  • Launch of promising pipeline products for dry eye disease (DED)
  • Incidence and prevalence of dry eye among different age groups

Major growth restraining factors:

  • Risk of side effects caused by eye drops
    • Since dry eye disease is caused due to numerous conditions, the primary treatment is using an eye drop.
    • However, there are several side effects associated with eye drops, such as blurred vision, watering eyes, sticky eyelashes, redness, increased sensitivity, swelling of eyelids, and discomfort
  • Accessibility of substitute therapies
  • High cost of specialty dry eye products

The report scope of the global dry eye disease market includes segmentation analysis based on type, product, and distribution channel. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Product:

  • Anti-inflammatory Drugs
    • The anti-inflammatory drugs segment held the highest market share across the product category in 2020.
    • Some of the anti-inflammatory drugs include Corticosteroid and Cyclosporine.
    • Cyclosporine-based drops are usually prescribed by doctors and physicians in the chronic stage of dry eye disease.
    • Corticosteroids are widely available, effective anti-inflammatory drugs that rapidly relieve the symptoms and signs of moderate and severe dry eye.
  • Artificial Tears
    • Artificial tears is set to be the fastest-growing product over the forecasted period.
    • Dryness of the eye happens due to low levels of tear production or the lack of the right quality tear film in the eye.
    • Artificial tear ware is extensively used for dry eye treatment. They help lubricate and maintain good moisture on the external surface of the eye.
  • Punctal Plugs
  • Secretagogues
  • Other Products

Geographically, the global dry eye disease market has been segmented based on four major regions, which includes:

  • North America: The United States and Canada
    • North America dominated the global market in 2020.
    • The United States is the largest and fastest-growing country in the North America dry eye disease market.
    • The market is anticipated to augment due to the increasing incidence of dry eye conditions or diseases. In addition, the rising healthcare spending for the treatment of dry eye is continually rising in the country. For instance, according to an article published in JAMA Internal Medicine, the United States spends more than $2 billion annually to treat dry eye disease.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Thailand, Indonesia, Singapore, and the Rest of Asia-Pacific
    • The Asia-Pacific Dry eye disease market is set to grow with the highest CAGR during the forecast period.
    • The factors likely to contribute to the market growth include the increasing incidence of dry eye disease among young people, owing to long hours spent in front of computers, the significantly rising geriatric population, the development of ophthalmic solutions, and the growing government support for eye health.
  • Rest of World: Latin America, the Middle East & Africa

Major market players operating in the global dry eye disease market:

  • Allergan PLC (Acquired by AbbVie)
  • Bausch Health Companies Inc
  • Johnson & Johnson
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd
  • Others

Key strategies adopted by some of these companies:

In August 2020, an announcement was made by Bausch Health Companies Inc to spin off its eye health business into an independent publicly traded company. Also, In October 2019, Sun Pharma launched CEQUA (cyclosporine ophthalmic solution) 0.09% in the United States. It is prescribed for increasing tear production in patients with dry eye disease.

Key findings of the global dry eye disease market:

  • Stem cell therapy is emerging in the treatment of dry eye conditions.
  • Ongoing research and developments related to dry eyes are set to provide the global market with lucrative opportunities.
  • Online pharmacies is the fastest-growing distribution channel.

 

Frequently Asked Questions (FAQs):

  • What are the stem cell technologies adopted for the treatment of dry eye disease?

A: Researchers focus on using cytokines and different cell sources such as mesenchymal stem cells to cure dry eye conditions.

  • What are the symptoms of dry eye disease?

A: Symptoms of dry eyes range from minor to severe burning, eye fatigue, itching, irritation, and even vision loss, leading to incapacity.

  • Who are the most vulnerable to dry eye disease?

A: The incidence of dry eye is commonly observed in older people aged 65 and above. Hence, the high prevalence of dry eye among the older population is likely to promote manufacturers to introduce new dry eye products in the market, which, in turn, contributes to the growth of the market.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • INTRODUCTION OF NOVEL DIAGNOSTIC TECHNIQUES FOR DRY EYE DISEASE (DED)
        • LAUNCH OF PROMISING PIPELINE PRODUCTS FOR DRY EYE DISEASE (DED)
        • INCIDENCE AND PREVALENCE OF DRY EYE AMONG DIFFERENT AGE GROUPS
      • KEY RESTRAINTS
        • RISK OF SIDE EFFECTS CAUSED BY EYE DROPS
        • ACCESSIBILITY OF SUBSTITUTE THERAPIES
        • HIGH COST OF SPECIALTY DRY EYE PRODUCTS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON DRY EYE DISEASE MARKET
      • KEY MARKET TRENDS
      •    PORTER’S FIVE FORCES ANALYSIS
        • THREAT OF NEW ENTRY
        • THREAT OF SUBSTITUTION
        • BUYERS POWER
        • SUPPLIERS POWER
        • COMPETITIVE RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY TYPE
      • OTC
      • PRESCRIPTION
    3. MARKET BY PRODUCT
      • ANTI-INFLAMMATORY DRUGS
        • CYCLOSPORINE
        • CORTICOSTEROID
        • OTHER ANTI-INFLAMMATORY DRUGS
      • ARTIFICIAL TEARS
      • PUNCTAL PLUGS
      • SECRETAGOGUES
      • OTHER PRODUCTS
    4. MARKET BY DISTRIBUTION CHANNEL
      • HOSPITAL PHARMACIES
      • INDEPENDENT PHARMACIES AND DRUG STORES
      • ONLINE PHARMACIES
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • SINGAPORE
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ALLERGAN PLC (ACQUIRED BY ABBVIE)
        • BAUSCH HEALTH COMPANIES INC
        • ESW VISION
        • JOHNSON & JOHNSON
        • LUMENIS
        • NICOX SA
        • NOVARTIS AG
        • OASIS MEDICAL
        • OTSUKA HOLDINGS CO LTD
        • SANTEN PHARMACEUTICAL CO LTD
        • SUN PHARMACEUTICAL INDUSTRIES LTD
        • SENTISS PHARMA PVT LTD
        • URSAPHARM ARZNEIMITTEL GMBH
        • VISUFARMA

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – DRY EYE DISEASE

    TABLE 2: GERIATRIC POPULATION ACROSS DIFFERENT REGIONS (60 YEARS & ABOVE)

    TABLE 3: GLOBAL DRY EYE DISEASE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: GLOBAL DRY EYE DISEASE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 5: GLOBAL OTC MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: GLOBAL OTC MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 7: GLOBAL PRESCRIPTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: GLOBAL PRESCRIPTION MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 9: GLOBAL DRY EYE DISEASE MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 10: GLOBAL DRY EYE DISEASE MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 11: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 12: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 13: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 14: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 15: GLOBAL CYCLOSPORINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 16: GLOBAL CYCLOSPORINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 17: GLOBAL CORTICOSTEROID MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 18: GLOBAL CORTICOSTEROID MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 19: GLOBAL OTHER ANTI-INFLAMMATORY DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 20: GLOBAL OTHER ANTI-INFLAMMATORY DRUGS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 21: GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 22: GLOBAL ARTIFICIAL TEARS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 23: GLOBAL PUNCTAL PLUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 24: GLOBAL PUNCTAL PLUGS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 25: GLOBAL SECRETAGOGUES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 26: GLOBAL SECRETAGOGUES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 27: GLOBAL OTHER PRODUCTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 28: GLOBAL OTHER PRODUCTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 29: GLOBAL DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 30: GLOBAL DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 31: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 32: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 33: GLOBAL INDEPENDENT PHARMACIES AND DRUG STORES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 34: GLOBAL INDEPENDENT PHARMACIES AND DRUG STORES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 35: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 36: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 37: GLOBAL DRY EYE DISEASE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 38: GLOBAL DRY EYE DISEASE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 39: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 40: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 41: LEADING PLAYERS OPERATING IN NORTH AMERICA DRY EYE DISEASE MARKET

    TABLE 42: EUROPE DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 43: EUROPE DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 44: LEADING PLAYERS OPERATING IN EUROPE DRY EYE DISEASE MARKET

    TABLE 45: ASIA-PACIFIC DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 46: ASIA-PACIFIC DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 47: LEADING PLAYERS OPERATING IN ASIA-PACIFIC DRY EYE DISEASE MARKET

    TABLE 48: REST OF WORLD DRY EYE DISEASE MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)

    TABLE 49: REST OF WORLD DRY EYE DISEASE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 50: LEADING PLAYERS OPERATING IN REST OF WORLD DRY EYE DISEASE MARKET

    TABLE 51: LIST OF MERGERS & ACQUISITIONS

    TABLE 52: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 53: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 54: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: GLOBAL DRY EYE DISEASE MARKET, BY TYPE, IN 2020

    FIGURE 6: GLOBAL DRY EYE DISEASE MARKET, BY OTC, 2021-2028 (IN $ MILLION)

    FIGURE 7: GLOBAL DRY EYE DISEASE MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

    FIGURE 8: GLOBAL DRY EYE DISEASE MARKET, BY PRODUCT, IN 2020

    FIGURE 9: GLOBAL DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, 2021-2028 (IN $ MILLION)

    FIGURE 10: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY CYCLOSPORINE, 2021-2028 (IN $ MILLION)

    FIGURE 11: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY CORTICOSTEROID, 2021-2028 (IN $ MILLION)

    FIGURE 12: GLOBAL ANTI-INFLAMMATORY DRUGS MARKET, BY OTHER ANTI-INFLAMMATORY DRUGS, 2021-2028 (IN $ MILLION)

    FIGURE 13: GLOBAL DRY EYE DISEASE MARKET, BY ARTIFICIAL TEARS, 2021-2028 (IN $ MILLION)

    FIGURE 14: GLOBAL DRY EYE DISEASE MARKET, BY PUNCTAL PLUGS, 2021-2028 (IN $ MILLION)

    FIGURE 15: GLOBAL DRY EYE DISEASE MARKET, BY SECRETAGOGUES, 2021-2028 (IN $ MILLION)

    FIGURE 16: GLOBAL DRY EYE DISEASE MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)

    FIGURE 17: GLOBAL DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, IN 2020

    FIGURE 18: GLOBAL DRY EYE DISEASE MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 19: GLOBAL DRY EYE DISEASE MARKET, BY INDEPENDENT PHARMACIES AND DRUG STORES, 2021-2028 (IN $ MILLION)

    FIGURE 20: GLOBAL DRY EYE DISEASE MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 22: UNITED STATES DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 23: CANADA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: EUROPE DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 25: GERMANY DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: FRANCE DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 27: UNITED KINGDOM DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 28: ITALY DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: RUSSIA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: BELGIUM DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: POLAND DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 32: REST OF EUROPE DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 33: ASIA-PACIFIC DRY EYE DISEASE MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 34: CHINA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 35: JAPAN DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 36: INDIA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 37: AUSTRALIA & NEW ZEALAND DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 38: SOUTH KOREA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 39: INDONESIA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 40: THAILAND DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 41: SINGAPORE DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 42: REST OF ASIA-PACIFIC DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 43: REST OF WORLD DRY EYE DISEASE MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 44: LATIN AMERICA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 45: MIDDLE EAST & AFRICA DRY EYE DISEASE MARKET, 2021-2028 (IN $ MILLION)

    1. MARKET BY TYPE
      • OTC
      • PRESCRIPTION
    2. MARKET BY PRODUCT
      • ANTI-INFLAMMATORY DRUGS
        • CYCLOSPORINE
        • CORTICOSTEROID
        • OTHER ANTI-INFLAMMATORY DRUGS
      • ARTIFICIAL TEARS
      • PUNCTAL PLUGS
      • SECRETAGOGUES
      • OTHER PRODUCTS
    3. MARKET BY DISTRIBUTION CHANNEL
      • HOSPITAL PHARMACIES
      • INDEPENDENT PHARMACIES AND DRUG STORES
      • ONLINE PHARMACIES
    4. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
      • ASIA-PACIFIC
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • CHINA
          • JAPAN
          • INDIA
          • AUSTRALIA & NEW ZEALAND
          • SOUTH KOREA
          • INDONESIA
          • THAILAND
          • SINGAPORE
          • REST OF ASIA-PACIFIC
      • REST OF WORLD
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • REGIONAL ANALYSIS
          • LATIN AMERICA
          • MIDDLE EAST & AFRICA

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now